Several studies from our laboratory and others have shown that inhibition of SPARC in both malignant cells in vitro[22], [24] and tumors in vivo[24], [25], [42] reduces melanoma growth, invasiveness, and induces spontaneous apoptotic cell death and anti-tumor cytotoxic capacity. The gene discussed is SPARC; the disease is neoplasm.